Clinical Trials
9 trialsNCT03534141 2025-05-16
MHALT
University of California, San Francisco
Phase NA Terminated
NCT05184283 2023-12-07
Utilization of MAsS in Patients Undergoing LT for HCC
Columbia University
Terminated
NCT00375011 2022-12-20
Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics
Meridian Bioscience, Inc.
Terminated
NCT01821963 2020-09-24
Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT02717949 2019-01-08
Optimal
University of Texas Southwestern Medical Center
Phase 4 Terminated
NCT00767936 2016-06-29
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Stanford University
Terminated
NCT00897312 2016-04-25
Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease
Vanderbilt-Ingram Cancer Center
Terminated
NCT00768001 2012-02-01
Genetic Analysis of Liver Cancer
Stanford University
Terminated
NCT00165633 2008-12-09
A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma
Eisai Inc.
Phase 2/3 Terminated